Connection

Zheng-Li Shi to Antibodies, Viral

This is a "connection" page, showing publications Zheng-Li Shi has written about Antibodies, Viral.
Connection Strength

0.502
  1. Countrywide Survey for MERS-Coronavirus Antibodies in Dromedaries and Humans in Pakistan. Virol Sin. 2018 Oct; 33(5):410-417.
    View in: PubMed
    Score: 0.075
  2. Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China. Virol Sin. 2018 02; 33(1):104-107.
    View in: PubMed
    Score: 0.072
  3. Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. Sci China Life Sci. 2017 12; 60(12):1399-1402.
    View in: PubMed
    Score: 0.070
  4. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses. Emerg Microbes Infect. 2021 Dec; 10(1):905-912.
    View in: PubMed
    Score: 0.023
  5. Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics. Nat Commun. 2021 08 09; 12(1):4887.
    View in: PubMed
    Score: 0.023
  6. Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates. Virol Sin. 2021 Oct; 36(5):879-889.
    View in: PubMed
    Score: 0.022
  7. A serological survey of SARS-CoV-2 in cat in Wuhan. Emerg Microbes Infect. 2020 Dec; 9(1):2013-2019.
    View in: PubMed
    Score: 0.022
  8. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020 06; 17(6):621-630.
    View in: PubMed
    Score: 0.021
  9. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020; 9(1):382-385.
    View in: PubMed
    Score: 0.021
  10. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry. J Virol. 2020 02 14; 94(5).
    View in: PubMed
    Score: 0.021
  11. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 03; 579(7798):270-273.
    View in: PubMed
    Score: 0.021
  12. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020; 9(1):275-277.
    View in: PubMed
    Score: 0.020
  13. Serological evidence of MERS-CoV and HKU8-related CoV co-infection in Kenyan camels. Emerg Microbes Infect. 2019; 8(1):1528-1534.
    View in: PubMed
    Score: 0.019
  14. Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya. Virol Sin. 2018 Dec; 33(6):484-492.
    View in: PubMed
    Score: 0.019
  15. Immunogenicity of the spike glycoprotein of bat SARS-like coronavirus. Virol Sin. 2010 Feb; 25(1):36-44.
    View in: PubMed
    Score: 0.010
  16. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species. J Immunol Methods. 2008 Feb 29; 331(1-2):1-12.
    View in: PubMed
    Score: 0.009
  17. A review of studies on animal reservoirs of the SARS coronavirus. Virus Res. 2008 Apr; 133(1):74-87.
    View in: PubMed
    Score: 0.008
  18. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020 Dec; 9(1):2571-2577.
    View in: PubMed
    Score: 0.005
  19. Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models. Emerg Microbes Infect. 2020 Dec; 9(1):2606-2618.
    View in: PubMed
    Score: 0.005
  20. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020 09 08; 324(10):951-960.
    View in: PubMed
    Score: 0.005
  21. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques. Cell Res. 2020 08; 30(8):670-677.
    View in: PubMed
    Score: 0.005
  22. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 04 28; 117(17):9490-9496.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.